Administrative Core

行政核心

基本信息

项目摘要

Project Summary – Administrative Core (AC) The role of the Administrative Core (AC) of the Indiana Alzheimer Disease Research Center (IADRC) is to provide strategic planning, management, resources, and oversight for the Center in support of its continued mission. The significance of this role is based on the U.S. National Plan for AD (NAPA), to prevent and effectively treat AD by 2025 through innovative research on etiology, early detection, and therapeutics. To help accomplish these goals the IADRC has proposed four Overall center aims for the IADRC renewal application: (1) Support, enhance, and expand innovative research on AD and related dementias targeting pathogenesis, diagnosis, treatment, and prevention; (2) Provide critical research resources and infrastructure to support existing studies and enable new innovative research, including a well-characterized longitudinally followed cohort of research participants; (3) Strongly support local, regional, and national/international dementia research collaborations to further the goals of the NIA, national ADRC Network, NAPA and related federal priorities; and, (4) Provide educational and training opportunities related to ADRD for learners of all levels, including those with diverse backgrounds and needs. The AC is responsible for overall management and strategic direction of the IADRC. Leadership within the Center and AC has been stable, with Dr. Andrew Saykin serving as the Center Director since 2013. Brad Glazier has long served as IADRC Administrator and Sarah Van Heiden is the new Research Operations Manager. The AC has six specific aims: (1) Overall direction and strategic planning for research on AD and related disorders. The AC will help to leverage existing strengths of programs and faculty and develop new opportunities for scientific growth and impact. It will also foster integration among the cores for thematic cohesion. The AC will coordinate the Executive Committee, including key leaders to advise and help implement the Center goals. (2) Provide administrative support, resource management and oversight functions. (3) Ensure ongoing evaluation and oversight of scientific progress, research and training. (4) Advance the IADRC goals of fostering and expanding innovative research, training and collaborative academic activities related to AD/ADRD. (5) Develop and manage the IADRC Developmental Projects Program, including solicitation of proposals, a robust and impartial review process, and tracking outcome metrics based on external funding and publication; and (6) Serving as an effective interface to important external organizations and promoting collaboration with other regional, national and international AD research initiatives. This includes interaction with the NIA as well as the NACC, NCRAD, ADNI, DIAN, LEADS, ACTC, ADGC/ADSP, AMP-AD, ADMC/ADMP, MODEL-AD, TREAT-AD and other consortia. The IADRC is committed to accomplishing these aims to support and accelerate progress in addressing the challenges of AD and related disorders.
项目摘要 – 行政核心 (AC) 印第安纳阿尔茨海默病研究中心 (IADRC) 行政核心 (AC) 的作用是 为中心提供战略规划、管理、资源和监督,以支持其持续发展 这一作用的重要性基于美国国家 AD 计划 (NAPA),旨在预防和预防 AD。 通过病因学、早期检测和治疗的创新研究,到 2025 年有效治疗 AD。 为了实现这些目标,IADRC 为 IADRC 续展申请提出了四个总体中心目标: (1) 支持、加强和扩大针对 AD 和相关痴呆症发病机制的创新研究, (2) 提供关键的研究资源和基础设施来支持 现有研究并启用新的创新研究,包括特征明确的纵向跟踪 研究参与者群体;(3) 大力支持地方、区域和国家/国际痴呆症 研究合作,以进一步实现 NIA、国家 ADRC 网络、NAPA 和相关联邦的目标 优先事项;以及 (4) 为各级学习者提供与 ADRD 相关的教育和培训机会, 包括具有不同背景和需求的人员。审计委员会负责整体管理和管理。 在 Andrew 博士的领导下,IADRC 的战略方向在中心和 AC 中一直保持稳定。 Saykin 自 2013 年起担任中心主任。Brad Glazier 长期担任 IADRC 管理员和 Sarah Van Heiden 是新任研究运营经理。AC 有六个具体目标:(1) 总体目标。 AD 及相关疾病研究的方向和战略规划将有助于利用现有的资源。 它还将为科学发展和影响力提供新的机会。 促进核心之间的整合以实现主题凝聚力。审计委员会将协调执行委员会, (2) 提供行政支持, (3) 确保持续的科学评估和监督。 (4) 推进 IADRC 促进和扩大创新研究的目标, 与 AD/ADRD 相关的培训和协作学术活动 (5) 制定和管理 IADRC。 发展项目计划,包括征求建议书、健全和公正的审查流程、 根据外部资金和出版物跟踪结果指标;(6) 充当有效的 与重要的外部组织建立联系,促进与其他区域、国家和地区的合作 国际 AD 研究计划。这包括与 NIA 以及 NACC、NCRAD 的互动。 ADNI、DIAN、LEADS、ACTC、ADGC/ADSP、AMP-AD、ADMC/ADMP、MODEL-AD、TREAT-AD 等 IADRC 致力于实现这些目标,以支持和加速进展。 应对 AD 和相关疾病的挑战。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ANDREW J SAYKIN其他文献

ANDREW J SAYKIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ANDREW J SAYKIN', 18)}}的其他基金

Longitudinal Blood-based Transcriptomic Changes in AD: Relation to Clinical and Biomarker Data
AD 中基于血液的纵向转录组变化:与临床和生物标志物数据的关系
  • 批准号:
    10555728
  • 财政年份:
    2023
  • 资助金额:
    $ 54.56万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10666609
  • 财政年份:
    2021
  • 资助金额:
    $ 54.56万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10475171
  • 财政年份:
    2021
  • 资助金额:
    $ 54.56万
  • 项目类别:
Indiana Alzheimer's Disease Research Center
印第安纳阿尔茨海默病研究中心
  • 批准号:
    10666607
  • 财政年份:
    2021
  • 资助金额:
    $ 54.56万
  • 项目类别:
Indiana Alzheimer's Disease Research Center
印第安纳阿尔茨海默病研究中心
  • 批准号:
    10264429
  • 财政年份:
    2021
  • 资助金额:
    $ 54.56万
  • 项目类别:
Indiana Alzheimer's Disease Research Center
印第安纳阿尔茨海默病研究中心
  • 批准号:
    10475170
  • 财政年份:
    2021
  • 资助金额:
    $ 54.56万
  • 项目类别:
STRUCTURAL AND FUNCTIONAL CONNECTIVITY IN SCHIZOPHRENIA
精神分裂症的结构和功能连接
  • 批准号:
    6988900
  • 财政年份:
    2004
  • 资助金额:
    $ 54.56万
  • 项目类别:
Genetics Core
遗传学核心
  • 批准号:
    10704681
  • 财政年份:
    2004
  • 资助金额:
    $ 54.56万
  • 项目类别:
Genetics Core
遗传学核心
  • 批准号:
    10495157
  • 财政年份:
    2004
  • 资助金额:
    $ 54.56万
  • 项目类别:
Neural Mechanisms of Chemotherapy-Induced Cognitive Dis
化疗引起的认知障碍的神经机制
  • 批准号:
    7106608
  • 财政年份:
    2003
  • 资助金额:
    $ 54.56万
  • 项目类别:

相似海外基金

Meeting the Challenges of COVID-19 by Expanding the Reach of Palliative Care: Proactive Advance Care Planning with Videos for the Elderly and all Patients with Dementia
通过扩大姑息治疗的范围来应对 COVID-19 的挑战:为老年人和所有痴呆症患者提供视频的主动预先护理计划
  • 批准号:
    10784057
  • 财政年份:
    2023
  • 资助金额:
    $ 54.56万
  • 项目类别:
Data Collection, Linkages, Cleaning and Sharing Core
数据采集​​、联动、清洗、共享核心
  • 批准号:
    10774555
  • 财政年份:
    2023
  • 资助金额:
    $ 54.56万
  • 项目类别:
The Paycheck Protection Program and its Effects on Staffing Patterns and the Outcomes of Residents Living with Dementia
薪资保护计划及其对人员配置模式和痴呆症居民结局的影响
  • 批准号:
    10729652
  • 财政年份:
    2023
  • 资助金额:
    $ 54.56万
  • 项目类别:
"Improving Health Equity in Long-Term Care Residents with Dementia: The Role of Race and Ethnicity in Resident-to-Resident Aggression"
“改善患有痴呆症的长期护理居民的健康公平:种族和民族在居民之间的攻击行为中的作用”
  • 批准号:
    10644715
  • 财政年份:
    2023
  • 资助金额:
    $ 54.56万
  • 项目类别:
Research Education Component
研究教育部分
  • 批准号:
    10729954
  • 财政年份:
    2023
  • 资助金额:
    $ 54.56万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了